Loading...

VVOS VIVOS THERAPEUTICS INC Delisting Actions 8-K Filing

VVS

VVS

VIVOS THERAPEUTICS INC

(VVOS)

2023 8-K

Show Summary

Summary

Asset Acquisitions

Asset Acquisitions

Financial Statements

Asset Purchase Agreement

Financial Results

Securities Offering

Annual Meeting Results

Q3 Financial Results

Annual Meeting Notice

Equity Incentive Plan

Q2 Financial Results

Non-Compliance with Nasdaq ...

Compliance with Stockholder...

Private Placement and Strat...

Delisting Notice

Financial Results Announcement

Compliance with Minimum Sto...

Financial Results Announcement

Entry Into a Material Defin...

Non-compliance notice from ...

Private Placement

Reverse Stock Split

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Delisting Notice

Change in Accounting Firm

Financial Results Announcement

Acquisition of Intellectual...

Private Placement

External Links:

Vivos Therapeutics received a notice from Nasdaq stating that its stockholders equity did not meet the minimum requirement, but it has 45 days to submit a plan to regain compliance.

AI Assistant

VIVOS THERAPEUTICS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.